from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0554/bpoC

LFCtreatmentdescriptionclass of inhibitor

-1.829

Amikacinug/mL Amikacintranslation

-1.636

Cap5-10ug/mL Capreomycintranslation

-2.165

Rox10-50 ug/mL Roxithromycintranslation

-0.566

SM2-5 ug/mL Streptomycintranslation

-3.531

Tet5-10 ug/mL Tetracyclinetranslation

-0.389

Rif0.2-5ug/mL Rifampicintranscription

-1.035

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.843

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.852

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.385

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.540

Clofazimine10-13 ug/mL Clofaziminerespiration

0.185

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.612

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.457

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.369

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.391

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.096

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.410

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.476

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.131

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.712

KCN5-20 ug/mL Potassium cyaniderespiration

0.111

NaN30.2-2 mM Sodium aziderespiration

0.718

Nigericin50 uM Nigericinrespiration

-1.505

TRC10-150 ug/mL Triclosanrespiration

-1.680

TRZ10-25 ug/mL Thioridazinerespiration

-1.567

Valinomycin0.5-10 uM Valinomycinrespiration

0.357

ZnSO42 mM ZnSO4respiration

-0.033

menadione6-10 ug/mL Menadionerespiration

0.154

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.677

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.066

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.001

NRP_1Non-replicating persistence stage 1dosRassociated

0.226

Amp0.2mg/mL AmpicillincellWall

0.559

Cephalexin20-100 ug/mL CephalexincellWall

0.510

Cerulenin0.32-5 ug/mL CerulenincellWall

0.598

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.367

EMB10-20 ug/mL EthambutolcellWall

0.624

Eta12-40 ug/mL EthionamidecellWall

0.809

INH0.2-0.4 ug/mL IsoniazidcellWall

0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.163

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.454

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.561

BZA0.12 mg/mL BenzamidearomaticAmides

0.689

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.531

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.283

H2O24 mM hydrogen peroxideDNAdamaging

1.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.773

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.981

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.741

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.839

UVUV-irradiationDNAdamaging

-1.272

ARP41-4 ug/mL Antitubercular compound ARP4?

0.923

Antimycin12.5-50 ug/mL Antimycin A?

0.412

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.561

PA_110-50 ug/mL Antitubercular compound PA-1?

0.400

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.549

PA8240.2-2 ug/mL PA-824?

-0.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.532

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.207

Verapamil50 uM Verapamil?

0.634

mercaptoethanol2 mM 2-Mercaptoethanol?

0.370

methoxatin10-20 ug/mL Methoxatin?